Β-Amyloid Burden is Not Associated with Cognitive Impairment in Schizophrenia: A Systematic Review
- 1 October 2016
- journal article
- research article
- Published by Elsevier in The American Journal of Geriatric Psychiatry
- Vol. 24 (10) , 923-939
Abstract
No abstract availableKeywords
Funding Information
- Canadian Institutes of Health Research
- CIHR (MOP-97946)
- Japan Society for the Promotion of Science (12J00172)
- Nakatomi Foundation
- Dainippon Sumitomo Pharma
- Kyowa Kirin
- Wiley Japan
- U.S. National Institutes of Health (RO1MH084886)
This publication has 100 references indexed in Scilit:
- Cortical Volume, Surface Area, and Thickness in Schizophrenia and Bipolar DisorderBiological Psychiatry, 2012
- PET amyloid-beta imaging in preclinical Alzheimer's diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2012
- Serotonin signaling is associated with lower amyloid-β levels and plaques in transgenic mice and humansProceedings of the National Academy of Sciences, 2011
- Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascadeThe Lancet Neurology, 2010
- APOE predicts amyloid‐beta but not tau Alzheimer pathology in cognitively normal agingAnnals of Neurology, 2010
- Cortical neuritic plaques and hippocampal neurofibrillary tangles are related to dementia severity in elderly schizophrenia patientsSchizophrenia Research, 2010
- Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's diseaseBrain, 2009
- Progressive brain structural changes mapped as psychosis develops in ‘at risk’ individualsSchizophrenia Research, 2009
- The biochemical womb of schizophrenia: A reviewIndian Journal of Clinical Biochemistry, 2008
- Neurocognitive Decline in Early-Onset Schizophrenia Compared With ADHD and Normal Controls: Evidence From a 13-Year Follow-up StudySchizophrenia Bulletin, 2008